GlassScriptPhysician profile
Aileen M King
NPI 1689623043
$1,510.21
in general payments reported to CMS, 2019-2025
23 companies · $64.43 in 2025
The $64.43 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $527 · 2020: $294 · 2021: $329 · 2022: $34.13 · 2023: $243 · 2024: $18.18 · 2025: $64.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $389.80 | 2019-2022 | |
| Therapeuticsmd, INC. | $186.67 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $121.85 | 2023 | Andexxa |
| Exact Sciences Corporation | $106.92 | 2023 | Cologuard Collection Kit |
| Coopersurgical, INC. | $86.03 | 2019-2023 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $78.28 | 2019-2021 | |
| Intuitive Surgical, INC. | $60.41 | 2021 | |
| Boston Scientific Corporation | $57.66 | 2020 | |
| Roche Diagnostics Corporation | $55.33 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $43.75 | 2019-2020 | |
| Allergan, INC. | $42.94 | 2019-2020 | |
| Hologic Sales and Service, LLC | $42.05 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.23 | 2019 | |
| Davol INC. | $33.59 | 2025 | Arista |
| Ethicon US, LLC | $28.14 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $27.58 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.32 | 2020 | |
| Avita Medical Americas, LLC | $18.18 | 2024 | |
| Organon LLC | $17.21 | 2021 | |
| Solventum Corporation | $16.96 | 2025 | Prevena |
| Biohaven Pharmaceuticals, INC. | $14.52 | 2021 | |
| Agile Therapeutics, INC. | $13.91 | 2021 | |
| Octapharma USA, INC. | $13.88 | 2025 | Fibryga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aileen King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.